Lav Aggarwal city New Delhi India covid-19 pandemic patient Lav Aggarwal city New Delhi India

Covid-19: DCGI approves emergency use of Gilead’s remdesivir

Reading now: 240
www.livemint.com

NEW DELHI: Drug Controller General of India V.G. Somani has approved the use of Gilead Sciences Inc’s novel drug remdesivir to treat covid-19 patients, Lav Aggarwal, joint secretary in the health ministry, said on Tuesday. “The DCGI gave an emergency use permission for remdesivir...

and this was based on evidence that was provided by the company to support its use against covid-19," Aggawal said at a press conference.

Aggarwal said further details on the protocols for use of the intravenous drug will be provided by the government in due course.

In India, Gilead has given voluntary licence for production of remdesivir to Cipla, Jubilant Life Sciences, Hetero Drugs and Mylan under a royalty-free arrangement till an alternative drug is found

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA